Вие сте тук

Каталог » Tokyo

Noevir Co. Ltd.

Noevir Co. Ltd. е Япония компания, която се намира в Tokyo. повече подробности по-долу.

Информация за компанията

  • Име на компанията: Noevir Co. Ltd.
  • Държава: Japan
  • Адрес: Tokyo
  • Контакт: Hiroshi Okura
  • уебсайт:
  • Профил: The Noevir Group Strives To Create A Flexible Strategy, Which Responds To Market Changes With Agility, While Nurturing Our Direct Sales Heritage. We Remain Firmly Committed To Maximizing Corporate Value For Our Stakeholders. This Has Been A Momentous Six Months For Noevir. On October 25, 2007 The Company´s Stock Was Listed On The Second Section Of The Tokyo Stock Exchange, And In 2008 We Celebrate The 30th Anniversary Of Noevir´s Establishment. I Believe That The Tse Listing Signals The Start Of A New Phase Of Dramatic Growth For Noevir, And On Behalf Of Everyone At The Company I Would Like Here To Express My Gratitude To Our Shareholders For Their Solid Support Over The Years. During The Reporting Six-month Period, The First Half Of The Company´s Fiscal 2008 Business Term, The Cosmetics Market In Japan Continued To Be The Scene Of Intense Competition, Featuring The Entry Of New Players From Other Industries And A Diversification In Marketing Channels. In These Circumstances, We Have Taken A Number Of Steps To Complement And Strengthen Our Direct Sales Activities: These Have Been Steadily Bearing Fruit, And We Are Now Ready For The Next Stage. To Improve Customer Convenience, In November 2007 We Opened Our First Noevir Style Showrooms In Sapporo And Kanazawa. This Is Part Of Our Strategy For Raising The Noevir Brand Profile In Regions Of Japan Other Than The Tokyo Area, Following The Launching Of The "noevir Style " Mail-order Service, As Well As The "noevir Support" Service To Ensure Smooth Deliveries To Our Sales Agents. In March 2008 We Opened A Similar Showroom In Nagoya. In The Field Of R&d, We Placed Top Priority On Basic Research, Focused On The Discovery Of Effective New Cosmetic Ingredients. We Also Continued Our Product Development Efforts, Centered On Sophisticated Foundation Products. In Its Drugstore Operations, Our Subsidiary Tokiwa Pharmaceutical Co., Ltd. Succeeded In Realizing A Steady Growth In Sales Of Nov-sana Brand Cosmetics. It Also Made A Significant Contribution To The Consolidated Business Performance With A Further Strengthening Its Position In The Health Beverage Market, Thanks To Good Sales Of The Energy Drink Min Min Da Ha. As A Result Of The Above, Sales For The Reporting First-half Period, On A Consolidated Basis, Came To ¥29,856 Million For An Increase Of 0.6% Over The Corresponding Period Of The Previous Year. Operating Income Came To ¥2,250 Million, Up 10.7% Year-on-year, While Ordinary Income Rose 5.7% To ¥2,390 Million, And Net Income Posted A Strong Increase Of 71.2% To ¥1,636 Million. For The Fiscal 2008 Full Term, Ending September 20, 2008, We Forecast Sales At ¥59,500 Million And Operating Income At ¥4,500 Million. Ordinary Income Is Projected At ¥5,000 Million, Due Partially To Gains On The Sale Of Real Estate Properties. Net Income Is Forecast At ¥2,700 Million, And Eps At ¥66.13.
  • Област: Tokyo
Допълнителни линкове

  • Nippon Polyurethane Ind. Co. Ltd.
  • Nitto Boseki Co. Ltd.
  • Noevir Co. Ltd.
  • Nof Corp.
  • Nomura Research Institute Ltd.

    •         ‹ предишна | следваща ›